Hao-wei X. Shen
Zhejiang Key Laboratory Of Pathophysiology, 818 Fenghua Rd
Ningbo, 315211, China
Ningbo, 315211, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Corrigendum "IRAS/Nischarin modulates morphine reward by glutamate receptor activation in the nucleus accumbens of mouse brain" [Biomed. Pharmacother. 153 (2022) 113346].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 22, 2026
Maraviroc attenuates inflammation-exacerbated cognitive and amyloid pathology in an early-stage Alzheimer's disease mouse model.
Journal: Translational psychiatry
Published: January 25, 2026
NMDAR glycine-site activation differentially modulates intrinsic properties of intratelencephalic and pyramidal-tract neuron via distinct ionic mechanisms.
Journal: Neurobiology of disease
Published: August 07, 2025
Advances in the study of pharmacotherapy for addiction to naturally-derived psychoactive substances.
Advances in the study of pharmacotherapy for addiction to naturally-derived psychoactive substances.
Journal: Chinese journal of natural medicines
Published: October 16, 2024
HCN2 deficiency correlates with memory deficits and hyperexcitability of dCA1 pyramidal neurons in Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: September 18, 2024
Adolescent exposure to the psychedelic 25C-NBOMe in rats induces lasting competitive avoidance through disrupted hippocampal-prefrontal synchrony.
Journal: Nature neuroscience
Published: August 20, 2024
The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex.
Journal: Psychopharmacology
Published: January 02, 2023
The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C-NBOMe in male rats.
Journal: Neuropharmacology
Published: November 07, 2022
D-serine reconstitutes synaptic and intrinsic inhibitory control of pyramidal neurons in a neurodevelopmental mouse model for schizophrenia.
Journal: Nature communications
Published: September 26, 2022
IRAS/Nischarin modulates morphine reward by glutamate receptor activation in the nucleus accumbens of mouse brain.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 17, 2022
Last Updated: 09/26/2026